Author | Haydee Verduzco-Aguirre, MD


69-Year-Old Man With Castration-Resistant Prostate Cancer Progressing After Docetaxel and Androgen Receptor-Targeting Agent

April 10, 2020

ByEduardo Gonzalez-Ochoa, MD|Haydee Verduzco-Aguirre, MD|E. David Crawford, MD|María T. Bourlon, MD, MSc

Experts discuss the case of a 69-year-old man with a history of metastatic prostate cancer previously treated with androgen deprivation therapy with leuprolide.